Oral Answers to Questions

Eric Ollerenshaw Excerpts

Wednesday 5th November 2014 Commons Chamber

[The Prime Minister]

We have taken a whole series of steps in difficult economic circumstances, of which the first is parity of esteem in the NHS constitution. We have seen a big expansion of talking therapies that were not available under the previous Government; we have introduced for the first time a waiting time standard for young people with psychosis, which never existed under the previous Labour Government; and we have, for the first time, a Minister with dedicated responsibility for child and adolescent mental health services. Of course much more needs to be done. The demands on our mental health services are very great, but the steps that I have mentioned have not been taken by previous Governments. We have managed to take them because we have put the money in and made important reforms to get rid of bureaucracy. All of those things are possible only if there is a strong economy backing a strong NHS.

[Eric Ollerenshaw (Lancaster and Fleetwood) (Con)]

Q3. On Saturday, the fountains of Trafalgar square, right through to Lancaster museum and Fleetwood’s Marine hall, were lit purple to raise awareness of pancreatic cancer. Will the Prime Minister look very carefully at the report produced last week by the all-party group on pancreatic cancer, with the support of Pancreatic Cancer UK, calling for more research into this dreadful disease before it becomes Britain’s fourth biggest killer in terms of cancer?

[The Prime Minister]

I pay tribute to my hon. Friend and the all-party group for the work that they do. I know how close this issue is to his heart and how much he feels this personally. The difficult situation here is that the one-year survival rate for those diagnosed with pancreatic cancer is about 20% and the five-year survival rate is only 5%, and that is not good enough. We are spending more money on research. We are investing a record £800 million over five years in a series of biomedical research centres, including the Liverpool pancreas biomedical research unit. We need the research to go in and for these new treatments to be properly tested so that we can improve these cancer survival rates as we have for other cancers.